Four Marijuana Stocks to Buy Now
The US marijuana industry has a lot of potential to grow and presents a good investment opportunity, although there is some uncertainty regarding the regulations.
Insys Therapeutics Inc. (INSY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Quantamental Technologies Ran Pang | 0 | $0 | 0% | |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.93 | 17,500 | Large Shareholder | 42,447,810 | 2017-08-11 | Filing | |
| $8.92 | 5,500 | Officer, Director | 15,400 | 2017-08-10 | Filing | |
| $11.10 | 5,400 | Officer, Director | 9,900 | 2017-06-14 | Filing | |
| $14.14 | 4,000 | Director | 4,000 | 2017-06-01 | Filing | |
| $12.21 | 8,000 | Director | 52,083 | 2017-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.41 | 166,504 | Director | 0 | 2018-05-10 | Filing | |
| $18.02 | 15,000 | Director | 2,000 | 2016-08-16 | Filing | |
| $18.46 | 15,000 | Director | 49,682 | 2016-08-11 | Filing | |
| $19.16 | 5,781 | Officer | 1 | 2016-08-09 | Filing | |
| $16.27 | 16,000 | Director | 2,000 | 2016-06-06 | Filing |
Institutional Investors' Holdings
News See All
Look Beyond Pharma to Invest in Marijuana Industry
In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ:CARA), Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE...
This Is How To Invest in the Marijuana Industry
Marijuana industry in the US is still in its inception phase, but it’s growing, and the projections are very optimistic.
True Leaf Seeks to Raise Capital as It Prepares to Enter into the Booming Canadian Marijuana Market
Canada is undoubtedly one of the greatest countries on earth. They’ve got universal healthcare, beautiful scenery, a whole region that speaks French and an awesome prime-minister.
Donald Trump On Weed Legalization: What's In Store For Marijuana Stocks?
While Canada is on the brink of legalizing Cannabis country-wide in 2017, the U.S is still engulfed in skepticism and legal ruffle about the substance.
12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
Cannabis has some undeniable medical benefits, to the point that there are several approved medical drugs that are derived from some of the chemical compounds (cannabinoids) in cannabis, including THC...
Hedge Funds Are Betting On Insys Therapeutics Inc (INSY)
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
How Hedge Funds Were Passing Around Marijuana Stocks in Q2
Even to people who are against the legalization of marijuana, it is common knowledge now that the legal marijuana industry is growing at a rapid pace and this growth should continue for many years.
Biotech Movers: Insys Therapeutics Inc (INSY) and Cempra Inc (CEMP)
The long weekend is over in the US, and the markets are back in full swing on Tuesday.
Top Bets of Parametrica Management - Barron’s Penta No. 1 Fund
The world’s premier investing publication Barron’s recently compiled Barron’s Penta annual hedge fund ranking and the top hedge fund vehicle on this year’s list is a big surprise indeed.